Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment …
Biotechnology
US, Houston [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Moleculin Biotech, Inc. (MBRX) to it's peer group.
Peer Group
AKTX PULM NXTC DFFN CAPR PMVP BPTH PBLA CFRX ALLR ANEB ONTX CYCC CBIO IKT ATXI ANTX MIRO
Compare Together
Loading...